Review of cannabinoids and their antiemetic effectiveness
- PMID: 6301800
- DOI: 10.2165/00003495-198300251-00006
Review of cannabinoids and their antiemetic effectiveness
Abstract
Marijuana has been used for over 2 centuries. Its major psychoactive constituent, delta-9-tetrahydrocannabinol (THC) was isolated in 1964 and first used to control nausea and vomiting during chemotherapy in the 1970s. THC has cardiovascular, pulmonary and endocrinological effects as well as actions on the central nervous system. Alterations in mood, memory, motor coordination, cognitive ability, sensorium, spatial- and self-perception are commonly experienced. The precise antiemetic mechanism is unknown. THC and nabilone act at a number of sites within the central nervous system. Cannabinoids have also been shown to inhibit prostaglandin synthesis in vitro. In controlled clinical trials, THC is superior to placebo and prochlorperazine in antiemetic effectiveness. Effectiveness of THC correlates to a 'high' experienced by the patient. A variety of chemotherapy regimens respond to THC including high-dose methotrexate and the doxorubicin, cyclophosphamide, fluorouracil combination. Cisplatin is more resistant. Side effects are generally well tolerated but may limit THC use in the elderly or when high doses are administered. Nabilone, a synthetic cannabinoid, is also an effective antiemetic which is more active than prochlorperazine in preventing chemotherapy-induced emesis, including cisplatin-containing regimens. Side effects are similar to THC and may be dose-limiting. Levonantradol, another synthetic cannabinoid, is an effective antiemetic. It may provide more flexibility in the outpatient setting since it can be administered orally or intramuscularly. Most side effects are mild except for dysphoria which may be dose-limiting.
Similar articles
-
A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics.Cancer Chemother Pharmacol. 2017 Sep;80(3):441-449. doi: 10.1007/s00280-017-3387-5. Epub 2017 Aug 5. Cancer Chemother Pharmacol. 2017. PMID: 28780725 Free PMC article. Review.
-
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.Cancer Chemother Pharmacol. 2017 Mar;79(3):467-477. doi: 10.1007/s00280-017-3257-1. Epub 2017 Feb 24. Cancer Chemother Pharmacol. 2017. PMID: 28235999 Review.
-
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.Ann Intern Med. 1979 Dec;91(6):825-30. doi: 10.7326/0003-4819-91-6-825. Ann Intern Med. 1979. PMID: 517882 Clinical Trial.
-
Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.Drug Alcohol Depend. 2011 Jul 1;116(1-3):86-92. doi: 10.1016/j.drugalcdep.2010.11.019. Epub 2011 Jan 11. Drug Alcohol Depend. 2011. PMID: 21227600 Free PMC article. Clinical Trial.
-
Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.Cancer Treat Rep. 1985 Jan;69(1):109-12. Cancer Treat Rep. 1985. PMID: 2981616 Clinical Trial.
Cited by
-
Therapeutic potential of cannabinoids in CNS disease.CNS Drugs. 2003;17(3):179-202. doi: 10.2165/00023210-200317030-00004. CNS Drugs. 2003. PMID: 12617697 Review.
-
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.Neurotherapeutics. 2009 Oct;6(4):713-37. doi: 10.1016/j.nurt.2009.08.002. Neurotherapeutics. 2009. PMID: 19789075 Free PMC article. Review.
-
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.J Headache Pain. 2018 May 24;19(1):37. doi: 10.1186/s10194-018-0862-2. J Headache Pain. 2018. PMID: 29797104 Free PMC article.
-
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.Cochrane Database Syst Rev. 2015 Nov 12;2015(11):CD009464. doi: 10.1002/14651858.CD009464.pub2. Cochrane Database Syst Rev. 2015. PMID: 26561338 Free PMC article. Review.
-
Effect of the synthetic cannabinoid nabilone on spermatogenesis in mice.Experientia. 1990 Aug 15;46(8):852-4. doi: 10.1007/BF01935536. Experientia. 1990. PMID: 2167237
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources